CDH17
Basic information
Region (hg38): 8:94127161-94217303
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (28 variants)
- not provided (10 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDH17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 28 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 29 | 4 | 5 |
Variants in CDH17
This is a list of pathogenic ClinVar variants found in the CDH17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-94128275-C-T | not specified | Uncertain significance (Dec 14, 2022) | ||
8-94128296-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
8-94130659-C-A | not specified | Uncertain significance (May 31, 2022) | ||
8-94130660-T-C | Benign/Likely benign (Apr 01, 2022) | |||
8-94130728-T-C | not specified | Uncertain significance (Oct 25, 2022) | ||
8-94130909-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
8-94130944-T-G | Benign (Jul 15, 2020) | |||
8-94130955-A-G | Likely benign (Dec 14, 2018) | |||
8-94145957-T-C | not specified | Uncertain significance (Jul 14, 2023) | ||
8-94145974-G-A | Benign (May 31, 2018) | |||
8-94145999-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
8-94146000-G-A | not specified | Uncertain significance (Apr 15, 2022) | ||
8-94146054-T-A | not specified | Uncertain significance (May 27, 2022) | ||
8-94146062-T-C | not specified | Uncertain significance (Dec 05, 2023) | ||
8-94146071-A-G | not specified | Uncertain significance (Aug 16, 2021) | ||
8-94146120-C-T | not specified | Uncertain significance (May 03, 2023) | ||
8-94148752-G-C | not specified | Uncertain significance (Jan 26, 2023) | ||
8-94148783-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
8-94148852-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
8-94151866-A-G | Uncertain significance (Oct 01, 2018) | |||
8-94151907-C-G | not specified | Uncertain significance (Nov 07, 2023) | ||
8-94151956-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
8-94151998-T-A | not specified | Likely benign (Feb 26, 2024) | ||
8-94152028-T-C | not specified | Uncertain significance (Oct 03, 2022) | ||
8-94152088-C-G | not specified | Uncertain significance (May 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDH17 | protein_coding | protein_coding | ENST00000027335 | 17 | 90133 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.42e-14 | 0.691 | 125582 | 0 | 164 | 125746 | 0.000652 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.351 | 438 | 459 | 0.954 | 0.0000238 | 5469 |
Missense in Polyphen | 120 | 140.91 | 0.85158 | 1813 | ||
Synonymous | -0.801 | 185 | 172 | 1.08 | 0.00000950 | 1620 |
Loss of Function | 1.74 | 27 | 38.7 | 0.698 | 0.00000197 | 464 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00256 | 0.00256 |
Ashkenazi Jewish | 0.000696 | 0.000695 |
East Asian | 0.000658 | 0.000653 |
Finnish | 0.0000932 | 0.0000924 |
European (Non-Finnish) | 0.000336 | 0.000334 |
Middle Eastern | 0.000658 | 0.000653 |
South Asian | 0.00167 | 0.00167 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. LI-cadherin may have a role in the morphological organization of liver and intestine. Involved in intestinal peptide transport. {ECO:0000269|PubMed:8153632}.;
- Pathway
- Gastric cancer - Homo sapiens (human);Cell-cell junction organization;Adherens junctions interactions;Cell junction organization;Cell-Cell communication
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.895
- rvis_EVS
- -0.3
- rvis_percentile_EVS
- 32.25
Haploinsufficiency Scores
- pHI
- 0.101
- hipred
- N
- hipred_score
- 0.462
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.386
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdh17
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- cell morphogenesis;germinal center B cell differentiation;marginal zone B cell differentiation;oligopeptide transport;cell-cell junction assembly;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;integrin-mediated signaling pathway;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;positive regulation of integrin activation by cell surface receptor linked signal transduction;adherens junction organization;oligopeptide transmembrane transport;cell-cell adhesion mediated by cadherin;spleen development;cell-cell adhesion
- Cellular component
- nucleus;plasma membrane;cell-cell adherens junction;cell surface;integral component of membrane;basolateral plasma membrane;catenin complex;cell junction
- Molecular function
- integrin binding;transporter activity;proton-dependent oligopeptide secondary active transmembrane transporter activity;calcium ion binding;cytoskeletal protein binding;protein homodimerization activity;cadherin binding